Results 161 to 170 of about 46,930 (188)

Clinical Factors Associated with Disease Severity in Symptomatic Dermographism: A Cross-Sectional Study. [PDF]

Medicina (Kaunas)
Akın Ö, Taşkapan MO, Cömert Erkılınç A, Tanrıöver Ö.   +3 more
europepmc   +1 more source

Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 274-285, July 2026.
BRAF inhibitors and MEK inhibitors (MEKi) have reshaped the treatment of BRAFV600‐mutant malignancies; however, cutaneous adverse drug reactions (ADRs) remain a frequent and clinically impactful toxicity. Although clinical trials provide insight into their safety profiles, real‐world data on dermatologic ADRs are limited.
Natalia Sauer, Piotr Giedziun, Jacek Calik, Anna Wiela‐Hojeńska   +3 more
wiley   +1 more source

Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine. [PDF]

Headache
Berger CT, Villena FB, Vogt SB, Heydrich L, Hartmann K, Papadopoulou A.   +5 more
europepmc   +1 more source

Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Center, Prospective, Observational Study (REVISE Study)

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
ICTI to evogliptin from other DPP‐4 inhibitors significantly improved glycemic control in patients with type 2 diabetes inadequately controlled on metformin‐based therapy. The treatment was well tolerated, supporting ICTI as a pragmatic optimization strategy in routine clinical practice. ABSTRACT Aims While dipeptidyl peptidase‐4 (DPP‐4) inhibitors are
Jie‐Eun Lee, Jun Hwa Hong, Sung Hoon Yu, Ki‐Hyun Baek, JaeMyung Yu, Seung Jin Lee, Hyung‐Wook Kim, Kang Seo Park, Jung Han Kim, KyungWan Min, Yong Hwan Lee, Koon Soon Kim, Min Soo Song, Ji Hoon Kim, Jong Chul Won   +14 more
wiley   +1 more source

Clinical and behavioral determinants in pediatric non-immediate drug hypersensitivity: Low confirmation but persistent avoidance. [PDF]

Pediatr Allergy Immunol
Can Bostan O, Soyer O, Papadopoulos M, Tsabouri S.   +3 more
europepmc   +1 more source

Occupational Contact Urticaria, Protein Contact Dermatitis and Concomitant Airway Diseases in the Finnish Register of Occupational Diseases in 2005–2020: Main Causes and Occupations at Risk

Contact Dermatitis, Volume 95, Issue 1, Page 74-85, July 2026.
This Finnish registry study shows that concomitant occupational asthma and rhinitis are common in patients with occupational contact urticaria or protein contact dermatitis, often sharing the same exposure. When evaluating occupational immediate allergy, both skin and airway symptoms should be considered.
Ville Ojanen, Liisa Airaksinen, Hille Suojalehto, Kirsi Koskela, Maria Pesonen   +4 more
wiley   +1 more source

A Rare Case of Yellow Urticaria Developing During Blood Transfusion. [PDF]

Cureus
Alsemairi LT, Ahmed A, Ibrahim AI, Zaytuni M, Aljohani KH.   +4 more
europepmc   +1 more source

An Autoethnography of My Experiences of Undergoing Fertility Treatment While Working as an Academic

Gender, Work &Organization, Volume 33, Issue 4, Page 1405-1415, July 2026.
ABSTRACT In this paper, I provide an autoethnographic account of my experiences of undergoing fertility treatment while working in a higher education institution in the United Kingdom. My autoethnographic reflections are situated in the context of neoliberal academia, characterized by high pressures to perform. Despite the prevalence of infertility and
Samantha Wilkinson
wiley   +1 more source

Chronic spontaneous urticaria treatments and purinergic signaling: a therapeutic possibility. [PDF]

J Mol Med (Berl)
Fontana M, Simões JLB, de Carvalho Braga G, Fontana M, Filho JCM, Bagatini MD.   +5 more
europepmc   +1 more source